Fagron Group Revenue and Competitors

USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Fagron Group's estimated annual revenue is currently $244.2M per year.(i)
  • Fagron Group's estimated revenue per employee is $201,000

Employee Data

  • Fagron Group has 1215 Employees.(i)
  • Fagron Group grew their employee count by 5% last year.

Fagron Group's People

NameTitleEmail/Phone
1
COOReveal Email/Phone
2
CEOReveal Email/Phone
3
VP, Quality and RegulatoryReveal Email/Phone
4
VP, Sales and Strategic GrowthReveal Email/Phone
5
VP FinanceReveal Email/Phone
6
SVP, General Counsel - North AmericaReveal Email/Phone
7
Senior Director, Trade RelationsReveal Email/Phone
8
Director ITReveal Email/Phone
9
Global ESG OfficerReveal Email/Phone
10
Global Innovations DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$85.6M4268%N/AN/A
Add Company

What Is Fagron Group?

Fagron's mission is to optimize and innovate personalized pharmaceutical care. \n\nFagron was founded in the Netherlands (Rotterdam) in 1990. Through a continuous focus on innovation, quality and solution-oriented thinking, Fagron obtained market leadership in pharmaceutical compounding. Today, our team develops, innovates and produces innovative concepts, products and formulas for compounding pharmacies, prescribers and patients in 35 countries worldwide.\n\nMore than 2.600 employees are located in offices, compounding facilities and plants in Fagron's key regions Benelux, Europe, North America, South America and the Pacific. The Belgian company Fagron NV is located in Waregem and is listed on Euronext Brussels and Euronext Amsterdam.

keywords:N/A

N/A

Total Funding

1215

Number of Employees

$244.2M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Fagron Group News

2022-04-17 - Global Cancer Supportive Care Drugs Market 2022 Research ...

Fagron Group; Teva Pharmaceuticals Industries; F.Hoffmann La-Roche Ltd; Apr Applied Pharma Science Research; Acacia Pharma; Kyowa Hakko Kirin...

2022-04-17 - Compounding Pharmacies Market Growth in Future Scope 2022 ...

... Central Admixture Pharmacy Services, Fagron, Fresenius Kabi AG, ... and represented by a group of specialists through the application of...

2022-03-22 - Fagron NV (EBR:FAGR) institutional owners may be pleased with recent gains after 14% loss over the past year

The group holding the most number of shares in the company, around 64% to be precise, is institutions. That is, the group stands to benefit the...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$432.1M1215N/AN/A
#2
$374.2M12156%N/A
#3
$75M12168%N/A
#4
$75M12175%N/A
#5
$418.1M12198%N/A